A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
Condition(s):Attention Deficit Hyperactivity Disorder (ADHD); Attention Deficit Hyperactivity DisorderLast Updated:November 1, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):Attention Deficit Hyperactivity Disorder (ADHD); Attention Deficit Hyperactivity DisorderLast Updated:November 1, 2018Withdrawn
Condition(s):Attention-Deficit/Hyperactivity Disorder (ADHD)Last Updated:August 24, 2012Withdrawn
Condition(s):HealthyLast Updated:January 21, 2016Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:July 11, 2011Completed
Condition(s):ADHDLast Updated:June 27, 2013Completed
Condition(s):Binge-Eating DisorderLast Updated:February 6, 2017Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:May 17, 2011Completed
Condition(s):ADHD; Attention Deficit Hyperactivity DisorderLast Updated:November 14, 2012Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:January 16, 2015Completed
Condition(s):Conduct Disorder; Attention Defict Hyperactivity DisorderLast Updated:December 3, 2019Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.